Caspofungin as Prophylaxis in High Risk Liver Transplantation Recipients

Summary

The aim of the study is to determine viable use of caspofungin in post-OLTx patients, and to demonstrate in particular the effectiveness, understood as the ability to reduce the incidence of invasive fungal infections, and to assess the ability to reduce the risk and incidence of side effects (toxicity) which may arise in transplant patients treated with other drugs, especially in individuals recognized as high risk (e.g. renal failure).

Timeline

Start

2009-05

Primary completion

2012-11

Completion

2012-11

Drugs

Indications